The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Wednesday, April 15, 2020
AstraZeneca Pharmaceuticals
AstraZeneca will initiate a randomized, global clinical trial to assess Calquence in the treatment of the exaggerated immune response associated with ...
read more
Wednesday, April 15, 2020
Samsung Bioepis announced ONTRUZANT® for HER2-overexpressing breast cancer, metastatic breast cancer, and metastatic gastric cancer or ...
read more
Wednesday, April 15, 2020
Xylyx Bio announced availability of products that recreate the lung environment in vitro to provide a predictive model that brings much-needed insight...
read more
Wednesday, April 15, 2020
Review the latest news and information on the COVID-19 Pandemic.
read more
Roivant Sciences announced the first patient was dosed in a trial evaluating the impact of IV treatment with gimsilumab on mortality in COVID-19 ...
read more
Regeneron announced the FDA has accepted for Priority Review a new BLA for REGN-EB3, an investigational triple antibody cocktail treatment for Ebola ...
read more
Review the latest news and information on the COVID-19 Pandemic.
read more
Pressure BioSciences announced the combination of PBI's patented Pressure Cycling Technology with RedShiftBio's proprietary Microfluidic Modulation ...
read more
Mind Medicine has begun dosing the first subject in an additional Phase 1 human safety trial of 18-MC.
read more
Review the latest news and information on the COVID-19 Pandemic.
read more
The FDA approved Tukysa in combination with chemotherapy for HER2-positive breast cancer that can't be removed with surgery, or has spread to other ...
read more
Review the latest news and information on the COVID-19 Pandemic.
read more
The FDA has granted accelerated approval to Pemazyre, the first treatment approved for adults with certain types of previously treated, advanced ...
read more
Stero Biotechs, in a collaboration with its main partner and shareholder, Mor Research Applications announced a new clinical trial in the global ...
read more
Review the latest news and information on the COVID-19 Pandemic.
read more